The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Surgical pathology findings of neoadjuvant full-dose irinotecan and cisplatin (IP) with concurrent thoracic radiation therapy (C-TRT) in stage III non-small cell lung cancer (NSCLC).
Paul R. Walker
No relevant relationships to disclose
Sharon Ben-Or
No relevant relationships to disclose
Jon Moran
No relevant relationships to disclose
Richard Fred Williams
No relevant relationships to disclose
Tithi Biswas
No relevant relationships to disclose
Daniel B. Fried
No relevant relationships to disclose
Julian Rosenman
No relevant relationships to disclose
Suzanne M. Russo
No relevant relationships to disclose
Raid Aljumaily
No relevant relationships to disclose
Mark Bowling
No relevant relationships to disclose
Susan Eubanks
No relevant relationships to disclose
Zenith Nelson
No relevant relationships to disclose
Teresa Parent
No relevant relationships to disclose